Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taddeo Kityamuweesi

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Open Forum Infectious Diseases|October 27, 2025
Herpesviruses Reactivation and Systemic Inflammation Before and After Initiating Antiretroviral Therapy Among Women with HIV in Rakai, UgandaVictor Ssempijja, Viviane Callier, Martha Nason, et al.
JCI Insight|June 17, 2020
Reduced HIV-1 latent reservoir outgrowth and distinct immune correlates among women in Rakai, UgandaJessica L Prodger, Adam A Capoferri, Katherine Yu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2017
Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, UgandaJessica L Prodger, Jun Lai, Steven J Reynolds, et al.
Virus Evolution|August 7, 2023
Dating reservoir formation in virologically suppressed people living with HIV-1 in Rakai, UgandaEdward Nelson Kankaka, Andrew D Redd, Amjad Khan, et al.
Nature Communications|July 2, 2024
HIV-1 subtype A1, D, and recombinant proviral genome landscapes during long-term suppressive therapyGuinevere Q Lee, Pragya Khadka, Sarah N Gowanlock, et al.
The Journal of Infectious Diseases|January 7, 2026
Estimating HIV-1 Viremic Time from Reservoir Sequence Diversity with Uncertainty QuantificationEdward N Kankaka, Stephen Tomusange, Taddeo Kityamuweesi, et al.
Emerging Microbes & Infections|March 6, 2024
Effective and targeted latency reversal in CD4<sup>+</sup> T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infectionMinh Ha Ngo, Joshua Pankrac, Ryan C Y Ho, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimenRoux-Cil Ferreira, Steven J Reynolds, Adam A Capoferri, et al.
Ebiomedicine|March 14, 2024
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimenRoux-Cil Ferreira, Steven J Reynolds, Adam A Capoferri, et al.
The Lancet. Microbe|March 15, 2025
Association between HIV-1 Nef-mediated MHC-I downregulation and the maintenance of the replication-competent latent viral reservoir in individuals with virally suppressed HIV-1 in Uganda: an exploratory cohort studyMitchell J Mumby, Jessica L Prodger, Jada Hackman, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Open Forum Infectious Diseases|October 27, 2025
Herpesviruses Reactivation and Systemic Inflammation Before and After Initiating Antiretroviral Therapy Among Women with HIV in Rakai, UgandaVictor Ssempijja, Viviane Callier, Martha Nason, et al.
JCI Insight|June 17, 2020
Reduced HIV-1 latent reservoir outgrowth and distinct immune correlates among women in Rakai, UgandaJessica L Prodger, Adam A Capoferri, Katherine Yu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 24, 2017
Reduced Frequency of Cells Latently Infected With Replication-Competent Human Immunodeficiency Virus-1 in Virally Suppressed Individuals Living in Rakai, UgandaJessica L Prodger, Jun Lai, Steven J Reynolds, et al.
Virus Evolution|August 7, 2023
Dating reservoir formation in virologically suppressed people living with HIV-1 in Rakai, UgandaEdward Nelson Kankaka, Andrew D Redd, Amjad Khan, et al.
Nature Communications|July 2, 2024
HIV-1 subtype A1, D, and recombinant proviral genome landscapes during long-term suppressive therapyGuinevere Q Lee, Pragya Khadka, Sarah N Gowanlock, et al.
The Journal of Infectious Diseases|January 7, 2026
Estimating HIV-1 Viremic Time from Reservoir Sequence Diversity with Uncertainty QuantificationEdward N Kankaka, Stephen Tomusange, Taddeo Kityamuweesi, et al.
Emerging Microbes & Infections|March 6, 2024
Effective and targeted latency reversal in CD4<sup>+</sup> T cells from individuals on long term combined antiretroviral therapy initiated during chronic HIV-1 infectionMinh Ha Ngo, Joshua Pankrac, Ryan C Y Ho, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2023
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimenRoux-Cil Ferreira, Steven J Reynolds, Adam A Capoferri, et al.
Ebiomedicine|March 14, 2024
Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimenRoux-Cil Ferreira, Steven J Reynolds, Adam A Capoferri, et al.
The Lancet. Microbe|March 15, 2025
Association between HIV-1 Nef-mediated MHC-I downregulation and the maintenance of the replication-competent latent viral reservoir in individuals with virally suppressed HIV-1 in Uganda: an exploratory cohort studyMitchell J Mumby, Jessica L Prodger, Jada Hackman, et al.
Pageof 2